Selective EGLN inhibition enables ablative radiotherapy and improves survival in unresectable pancreatic cancer

Tara N. Fujimoto, Lauren E. Colbert, Yanqing Huang, Jessica M. Molkentine, Amit Deorukhkar, Laura Baseler, B. De La Cruz B., Meifang Yu, Daniel Lin, Sonal Gupta, Peter K. Cabeceiras, Charles V. Kingsley, Ramesh C. Tailor, Gabriel O. Sawakuchi, Eugene J. Koay, Helen Piwnica-Worms, Anirban Maitra, Cullen M. Taniguchi